Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has issued an update.
Shanghai Pharmaceuticals Holding Co., Ltd. announced an interim cash dividend of RMB 1.2 per 10 shares for the six months ending June 30, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence its market positioning by showcasing financial stability and shareholder confidence.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.50 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and services. The company is a key player in the healthcare market, providing a wide range of medical products and solutions.
Average Trading Volume: 3,259,649
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$77.57B
For an in-depth examination of 2607 stock, go to TipRanks’ Overview page.